Home / Companies / Standard BioTools Inc. / 18 Jun 2025
Standard BioTools Inc.: meeting of 18 Jun 2025
Votes reported on Form N-PX, item by item
193 Form N-PX filers reported votes at the Standard BioTools Inc. meeting of 18 Jun 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 91.1% of reported votes for; 14 filers withheld from or voted against at least one nominee.
234 vote records from 64 filers. 1 of the 64 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
271 vote records from 192 filers. 21 of the 183 filers that marked the item either way voted against management. 9 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
117 vote records from 64 filers. 0 of the 64 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
117 vote records from 64 filers. 30 of the 64 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | No report | For | No report |
| State Street and SPDR | Split or no vote | For | For |
| Franklin Templeton | For | For | For |
| Invesco | No report | Against * | No report |
| Equitable | For | For | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | Split or no vote | For | For |
| ProShares and ProFunds | For | For | For |
| John Hancock and Manulife | For | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For |
| J.P. Morgan | No report | For | No report |
| Goldman Sachs | For | For | For |
| PGIM and Prudential | No report | For | No report |
| Northern Trust and FlexShares | Split or no vote | For | For |
| SEI | For | For | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | Split or no vote | For | For |
| Voya | For | For | For |
| Nationwide | For | For | For |
| Victory Capital | For | For | For |
| Brighthouse Funds | For | For | For |
| Guggenheim and Rydex | For | For | For |
| Columbia Threadneedle | Split or no vote | For | For |
| BNY Mellon | No report | For | No report |
| Principal | No report | For | No report |
| Pacific Life funds | For | For | For |
| Global X | For | For | For |
| Federated Hermes | For | For | For |
| AllianceBernstein | No report | Against * | No report |
| DWS | For | For | For |
| Neuberger Berman | For | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Standard BioTools Inc. meeting?
193 Form N-PX filers reported votes at the meeting of 18 Jun 2025. On say-on-pay, 21 of 183 voted against management (11.5%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Standard BioTools Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Standard BioTools Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Standard BioTools Inc. with a meeting date within three days of 18 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.